ARX Aroa Biosurgery Limited
—Mkt Cap: —P/E: —1d ago
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endofo…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value114.58M USD
Revenue (TTM)71.77M USD
Gross Profit51.19M USD
Net Income (TTM)2.70M USD
Revenue/Share0.30 AUD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINNZARXE0001S1
Valuation
P/E (Trailing)—
P/E (Forward)18.66
PEG—
EV/EBITDA18.76
EV/Revenue1.60
P/S1.82
P/B2.33
EPS (TTM)0.01
EPS (Forward)0.03
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin85.53%
Oper. Margin11.96%
EBITDA Margin8.51%
Profit Margin4.50%
ROE4.71%
ROA3.88%
Growth
Revenue Growth29.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.29M USD
CapEx (TTM)2.15M USD
FCF Margin6.33%
FCF Yield—
Net Debt-14.35M USD
Net Debt/EBITDA-2.35
Balance Sheet
Debt/Equity0.06
Current Ratio4.77
Quick Ratio4.18
Book Value/Sh0.23 AUD
Cash/Share0.08 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.083 AUD
Target Range0.7938 AUD – 1.360 AUD
# Analysts3
Ownership
Shares Out.350.28M
Float260.13M
Insiders27.28%
Institutions32.94%
Technical
SMA 500.5438 AUD
SMA 2000.6029 AUD
Beta0.86
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)453.39K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—